Uroplasty, Inc. (UPI) Tops Q2 EPS by 2c

Uroplasty, Inc. (NASDAQ: UPI) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $6.45 million versus the consensus estimate of $6.43 million.

For earnings history and earnings-related data on Uroplasty, Inc. (UPI) click here.

You May Also Be Interested In

• Wolverine World Wide (WWW) Tops Q2 EPS by 2c; offers guidance
• JD.com (JD) Tops Q1 EPS by 66c
• Nauticus Robotics (KITT) Reports Q2 Loss of $2.30